CA985685A - Process for the preparation of 2-amino-4,5-dihydropyridine derivatives and compounds thereby produced - Google Patents

Process for the preparation of 2-amino-4,5-dihydropyridine derivatives and compounds thereby produced

Info

Publication number
CA985685A
CA985685A CA165,183A CA165183A CA985685A CA 985685 A CA985685 A CA 985685A CA 165183 A CA165183 A CA 165183A CA 985685 A CA985685 A CA 985685A
Authority
CA
Canada
Prior art keywords
amino
compounds
preparation
produced
dihydropyridine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA165,183A
Other languages
English (en)
Other versions
CA165183S (en
Inventor
Kurt Stoepel
Friedrich Bossert
Horst Meyer
Wulf Vater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2210650A external-priority patent/DE2210650C3/de
Priority claimed from DE19722260860 external-priority patent/DE2260860A1/de
Application filed by Bayer AG filed Critical Bayer AG
Application granted granted Critical
Publication of CA985685A publication Critical patent/CA985685A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
CA165,183A 1972-03-06 1973-03-05 Process for the preparation of 2-amino-4,5-dihydropyridine derivatives and compounds thereby produced Expired CA985685A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2210650A DE2210650C3 (de) 1972-03-06 1972-03-06 2-Amino-6-alkoxy-4,5-dihydropyridin-3,5-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE19722260860 DE2260860A1 (de) 1972-12-13 1972-12-13 Verfahren zur herstellung von neuen 2-amino-6-alkylmercapto-4,5-dihydropyridinen sowie ihre verwendung als antihypertensiva

Publications (1)

Publication Number Publication Date
CA985685A true CA985685A (en) 1976-03-16

Family

ID=25762843

Family Applications (1)

Application Number Title Priority Date Filing Date
CA165,183A Expired CA985685A (en) 1972-03-06 1973-03-05 Process for the preparation of 2-amino-4,5-dihydropyridine derivatives and compounds thereby produced

Country Status (16)

Country Link
US (1) US3876646A (xx)
JP (1) JPS5626658B2 (xx)
AT (1) AT325614B (xx)
CA (1) CA985685A (xx)
CH (1) CH580591A5 (xx)
CS (1) CS179980B2 (xx)
DD (1) DD106832A5 (xx)
DK (1) DK135714C (xx)
ES (1) ES412320A1 (xx)
FR (1) FR2183673B1 (xx)
GB (1) GB1374551A (xx)
HU (1) HU167088B (xx)
IE (1) IE37367B1 (xx)
IL (1) IL41666A (xx)
NL (1) NL7303134A (xx)
SE (1) SE384206B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3951993A (en) * 1972-03-06 1976-04-20 Bayer Aktiengesellschaft 2-Amino-4,5-dihydropyridine derivatives and process for their preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1923990C3 (de) * 1969-05-10 1978-11-23 Bayer Ag Verfahren zur Herstellung von N-substituierten M-Dihydropyridin-S.S-dicarbonsäureestern
DE2013431C3 (de) * 1970-03-20 1979-12-20 Bayer Ag, 5090 Leverkusen 4-Azidophenyl-l,4-dihydropyridin-3,5-dicarbonsäureester
DE1963186C3 (de) * 1969-12-17 1979-02-15 Bayer Ag, 5090 Leverkusen Schwefelhaltige 1,4-Dihydropyridin-33-dicarbonsäureester
ZA7152B (en) * 1970-01-24 1971-10-27 Bayer Ag New pharmaceutically active 1,4-dihydropyridines
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
FR2183673B1 (xx) 1976-12-03
DK135714B (da) 1977-06-13
GB1374551A (en) 1974-11-20
US3876646A (en) 1975-04-08
DK135714C (da) 1977-11-14
DD106832A5 (xx) 1974-07-05
SE384206B (sv) 1976-04-26
IE37367B1 (en) 1977-07-06
FR2183673A1 (xx) 1973-12-21
JPS4899180A (xx) 1973-12-15
IL41666A (en) 1976-02-29
NL7303134A (xx) 1973-09-10
JPS5626658B2 (xx) 1981-06-19
HU167088B (xx) 1975-08-28
AT325614B (de) 1975-10-27
CH580591A5 (xx) 1976-10-15
ES412320A1 (es) 1976-04-16
ATA196973A (de) 1975-01-15
CS179980B2 (en) 1977-12-30
IE37367L (en) 1973-09-06
IL41666A0 (en) 1973-05-31

Similar Documents

Publication Publication Date Title
CA1027946A (en) Process for the preparation of 5-fluorouracil derivatives
CA1016544A (en) Process for the preparation of bicyclic derivatives of 1,4-dihydropyridine
CA989827A (en) Process for the preparation of 14-hydroxymorphinan derivatives
AU472802B2 (en) Process for the preparation of 3-nitro-4-amino-toluene
CA1003410A (en) Process for the preparation of alpha-6-deoxytetracyclines
AU471441B2 (en) Process for the preparation of 2-hydrazino-benzothiazoles
AU474746B2 (en) Process for the preparation of thiazole-sulphenamides
CA993871A (en) Process for the preparation of certain indolobenzazepine derivatives
CA985685A (en) Process for the preparation of 2-amino-4,5-dihydropyridine derivatives and compounds thereby produced
CA982126A (en) Benzotriazocine derivatives and process for the preparation thereof
CA1010860A (en) Process for the manufacture of new anhydrofuranose derivatives
CA1018182A (en) Process for the preparation of alkylene-bis-amides
CA1005058A (en) Process for the preparation of unsymmetrically-substituted alkanolamino-s-triazines
CA1019097A (en) Process for the preparation of trans-polyalkenamers
CA1006114A (en) Process for the preparation of chloroiminophosgene
CA913104A (en) Process for the preparation of isoquinuclidine derivatives
CA894805A (en) Process for the preparation of dibenzo-cycloheptene derivatives
CA989828A (en) Process for the preparation of 14-hydroxymorphinan derivatives
CA913103A (en) Process for the preparation of isoquinuclidine derivatives
CA898261A (en) Process for the preparation of 2-alkyl-4,5-diphenylpyrrole derivatives
CA896553A (en) Benzothiazines, related compounds, derivatives and salts thereof and the process of preparation
CA902082A (en) Process for the manufacture of sulfonyl-urea derivatives
CA898806A (en) Process for the preparation of 1,4-benzodiazepine derivatives
CA900477A (en) Pyrimidine derivatives and process for the preparation thereof
CA914189A (en) Process for the manufacture of pyrimidine derivatives